Corpus 1,285 assessed · 1,186 scored · 647 reproduced ≥75 · 174 flagged ·∅ 73.9/100

Publications 1 Datasets 392.5k Experiments 6.2k

Explore

Filters: Chemotherapy ✕ dna microarray (gene expression) ✕ breast tumor tissue, ouh patients ✕ clear all

1 matching publication(s)

Publication	Journal	Year	Score	Verdict
IRSN-23 gene diagnosis enhances breast cancer subtype classification and predicts response to neoadjuvant chemotherapy: new validation analyses. PMID 40128415	Breast Cancer	2025	71	L1 71/100

IRSN-23 gene diagnosis enhances breast cancer subtype classification and predicts response to neoadjuvant chemotherapy: new validation analyses.

PMID 40128415 · Breast Cancer · 2025

L1 71/100